Jeffrey S. Parkin

Array ( [id] => 5807695 [patent_doc_number] => 20060094049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Stabilized viral envelope proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/261390 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19750 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094049.pdf [firstpage_image] =>[orig_patent_app_number] => 11261390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655242 [patent_doc_number] => 20060140977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion' [patent_app_type] => utility [patent_app_number] => 11/259540 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15640 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140977.pdf [firstpage_image] =>[orig_patent_app_number] => 11259540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004555 [patent_doc_number] => 20070202123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids' [patent_app_type] => utility [patent_app_number] => 11/253274 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 84 [patent_figures_cnt] => 84 [patent_no_of_words] => 37528 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202123.pdf [firstpage_image] =>[orig_patent_app_number] => 11253274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7730184 [patent_doc_number] => 08101739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-24 [patent_title] => 'Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector' [patent_app_type] => utility [patent_app_number] => 11/662869 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 57 [patent_no_of_words] => 13308 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/101/08101739.pdf [firstpage_image] =>[orig_patent_app_number] => 11662869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 334006 [patent_doc_number] => 07507417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-24 [patent_title] => 'Immunogenic compositions comprising human immunodeficiency virus type 2 (HIV-2) glycosylated and unglycosylated envelope proteins and their methods of preparation' [patent_app_type] => utility [patent_app_number] => 11/235527 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 13123 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/507/07507417.pdf [firstpage_image] =>[orig_patent_app_number] => 11235527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4739478 [patent_doc_number] => 20080233131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Vaccine' [patent_app_type] => utility [patent_app_number] => 11/575280 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7103 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233131.pdf [firstpage_image] =>[orig_patent_app_number] => 11575280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4531905 [patent_doc_number] => 07888003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Methods for the detection of HIV-1 antibodies employing polypeptides obtained from gag P6 protein' [patent_app_type] => utility [patent_app_number] => 11/662370 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 37035 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888003.pdf [firstpage_image] =>[orig_patent_app_number] => 11662370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 44467 [patent_doc_number] => 07777020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Nucleotide sequences derived from the env gene of HIV-1' [patent_app_type] => utility [patent_app_number] => 11/203127 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7469 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/777/07777020.pdf [firstpage_image] =>[orig_patent_app_number] => 11203127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4612161 [patent_doc_number] => 07988975 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-02 [patent_title] => 'Modified HIV-1 group M cyclic gp41 peptides and their use in the detection of anti-HIV-1 antibodies' [patent_app_type] => utility [patent_app_number] => 11/659491 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7285 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/988/07988975.pdf [firstpage_image] =>[orig_patent_app_number] => 11659491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514282 [patent_doc_number] => 20090214588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Vaccines against aids comprising cmv/r-nucleic acid constructs' [patent_app_type] => utility [patent_app_number] => 11/632522 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25869 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214588.pdf [firstpage_image] =>[orig_patent_app_number] => 11632522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 585272 [patent_doc_number] => 07446170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => 'Method for gene transfer into target cells with retrovirus' [patent_app_type] => utility [patent_app_number] => 11/181091 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 27819 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/446/07446170.pdf [firstpage_image] =>[orig_patent_app_number] => 11181091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 190740 [patent_doc_number] => 07642051 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-05 [patent_title] => 'Screening methods for the identification of inhibitors of human immunodeficiency virus (HIV) viral protein R (Vpr) binding to the adenine nucleotide translocator (ANT)' [patent_app_type] => utility [patent_app_number] => 11/176370 [patent_app_country] => US [patent_app_date] => 2005-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 27 [patent_no_of_words] => 14872 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/642/07642051.pdf [firstpage_image] =>[orig_patent_app_number] => 11176370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228915 [patent_doc_number] => 20100183653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Fusion Proteins Comprising CD4 Minimal Modules and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 11/597340 [patent_app_country] => US [patent_app_date] => 2005-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 27421 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183653.pdf [firstpage_image] =>[orig_patent_app_number] => 11597340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865069 [patent_doc_number] => 20060099199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Peroxiredoxin drugs for treatment of HIV-1 infection and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/145558 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15381 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099199.pdf [firstpage_image] =>[orig_patent_app_number] => 11145558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585393 [patent_doc_number] => 20090104595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Methods for determining the sensitivity or resistance of retrovirus isolates to therapeutic retroviral treatments based on viral protease inhibitors and diagnostic kits' [patent_app_type] => utility [patent_app_number] => 11/628120 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5031 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104595.pdf [firstpage_image] =>[orig_patent_app_number] => 11628120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5062573 [patent_doc_number] => 20070224212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Stable Peptide Mimetic of Hiv Gp41 Fusion Intermediate' [patent_app_type] => utility [patent_app_number] => 11/628483 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 57295 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224212.pdf [firstpage_image] =>[orig_patent_app_number] => 11628483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619339 [patent_doc_number] => 20060188872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Novel post-transcriptional regulatory elements and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/130545 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19200 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188872.pdf [firstpage_image] =>[orig_patent_app_number] => 11130545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8081043 [patent_doc_number] => 08147840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-03 [patent_title] => 'Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid' [patent_app_type] => utility [patent_app_number] => 11/596494 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 30 [patent_no_of_words] => 17762 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/147/08147840.pdf [firstpage_image] =>[orig_patent_app_number] => 11596494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769547 [patent_doc_number] => 20050266025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Novel use' [patent_app_type] => utility [patent_app_number] => 11/119212 [patent_app_country] => US [patent_app_date] => 2005-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 13115 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266025.pdf [firstpage_image] =>[orig_patent_app_number] => 11119212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5514277 [patent_doc_number] => 20090214583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Epitope-enhancement of a human cd4 hiv epitope' [patent_app_type] => utility [patent_app_number] => 11/579230 [patent_app_country] => US [patent_app_date] => 2005-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9195 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20090214583.pdf [firstpage_image] =>[orig_patent_app_number] => 11579230 [rel_patent_id] =>[rel_patent_doc_number] =>)